QA: Neos Therapeutics Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001467652_2018_Neos_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001467652')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001467652, Neos Therapeutics Inc.

  xvar xval
0 AssetsCurrent 82,640,000
1 IntangibleAssetsNetIncludingGoodwill 16,348,000
2 PropertyPlantAndEquipmentNet 8,203,000
3 remainder_Assets 162,000
4 LiabilitiesCurrent 37,602,000
5 LiabilitiesNoncurrent 61,861,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 12,391,000
8 SellingGeneralAndAdministrativeExpense 13,805,000
9 ResearchAndDevelopmentExpense 8,957,000
10 remainder_Expenses 46,881,000
11 remainder_Revenues 25,018,000
12 remainder_NetIncome -9,231,000
13 remainder_ComprehensiveNetIncome -5,000
  yvar yval
0 Assets 107,353,000
1 Liabilities 99,463,000
2 Expenses 82,034,000
3 Revenues 25,018,000
4 StockholdersEquity 7,890,000
5 NetIncome -66,247,000
6 ComprehensiveNetIncome -66,249,500
7 BaseVar 161,552,000
8 EconomicCapitalRatio -0.509

Edgar->Model Mapping

Feature Distribution

Change over Time